Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
CentreStone Ventures Inc. is a private venture capital fund based in Winnipeg, Manitoba, founded to invest in early-stage life sciences companies. Established with a focus on therapeutics, medical devices, diagnostics, and drug delivery methods, the firm aims to support innovations that address significant clinical needs. The organization emphasizes investments in companies that possess strong intellectual property and entrepreneurial expertise.
Currently, CentreStone Ventures operates with a keen interest in opportunities within Western Canada and the U.S. Midwest. The firm primarily targets pre-seed, seed, and seed-plus stages, allowing it to engage with startups at critical points in their development. This strategic focus positions CentreStone Ventures as a key player in the life sciences investment landscape.
CentreStone Ventures invests in early-stage life sciences companies, specifically in the sectors of biotech and healthcare. The firm targets companies developing therapeutics, medical devices, diagnostics, and innovative drug delivery methods. Their investment strategy is designed to identify and support startups that are addressing large markets with unmet clinical needs.
Geographically, CentreStone Ventures concentrates on Western Canada and the U.S. Midwest, seeking opportunities that align with their investment thesis. The firm looks for companies that not only have solid intellectual property but also possess the entrepreneurial expertise necessary to navigate the complexities of the life sciences sector.
CentreStone Ventures has not publicly disclosed specific portfolio companies. However, the firm is known to invest in early-stage companies within the life sciences sector, particularly those developing therapeutics, medical devices, diagnostics, and drug delivery methods. The emphasis on addressing unmet clinical needs suggests that the firm is likely to support startups that are pioneering innovative solutions in these areas.
While specific outcomes for portfolio companies are not available, the firm’s focus on solid intellectual property and entrepreneurial expertise indicates a preference for companies that have the potential for significant market impact. This strategic approach positions CentreStone Ventures to contribute to the growth of the life sciences industry in North America.
Dr. Albert D. Friesen - President. Dr. Friesen has extensive experience in the life sciences sector and leads the strategic direction of CentreStone Ventures.
Mr. Marcus Enns - Vice President, Corporate Affairs. Mr. Enns manages corporate communications and stakeholder relations, bringing a wealth of knowledge in corporate strategy.
Mr. James Kinley, CA - Financial Operations Manager. Mr. Kinley oversees financial operations and reporting, ensuring the firm maintains robust financial health.
Startups looking to pitch to CentreStone Ventures should submit their proposals through the firm’s website or reach out directly to team members. A well-structured pitch deck should include information about the business model, market opportunity, and intellectual property. While specific response time expectations are not provided, founders should anticipate a thorough review process.
CentreStone Ventures has not publicly reported any recent investments, exits, or fund raises. The firm continues to focus on identifying promising early-stage life sciences companies in its target regions.
What are CentreStone Ventures' investment criteria?
CentreStone Ventures focuses on early-stage life sciences companies, particularly those in therapeutics, medical devices, diagnostics, and drug delivery methods. They seek startups that address large markets with unmet clinical needs and have strong intellectual property.
How can I apply or pitch to CentreStone Ventures?
Founders interested in pitching to CentreStone Ventures should prepare a detailed presentation that outlines their business model, market opportunity, and intellectual property. Direct contact through their website is recommended for initial outreach.
What makes CentreStone Ventures different from other investors?
CentreStone Ventures specializes in early-stage life sciences investments, with a specific focus on Western Canada and the U.S. Midwest. Their emphasis on unmet clinical needs and strong intellectual property sets them apart in the venture capital landscape.
What is the geographic scope of CentreStone Ventures?
The firm primarily invests in Western Canada and the U.S. Midwest, targeting early-stage life sciences companies within these regions.
What is the typical check size for investments?
While specific check sizes are not disclosed, CentreStone Ventures focuses on pre-seed, seed, and seed-plus stages, which typically involve smaller initial investments to support early development.
What kind of post-investment involvement does CentreStone Ventures have?
CentreStone Ventures actively supports its portfolio companies through mentorship and guidance, leveraging their expertise in the life sciences sector to help startups navigate challenges and achieve growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.